Dow Down 0.39% Nasdaq Up 0.04%

More On ZLCS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Zalicus Inc. (ZLCS)

-NasdaqCM
1.18 Up 0.03(2.61%) Jul 15 - Nasdaq Real Time Price
Prev Close:1.18
Open:1.18
Bid:N/A
Ask:N/A
1y Target Est:1.20
Beta:1.93
Next Earnings Date:N/A
Day's Range:1.13 - 1.29
52wk Range:0.86 - 8.28
Volume:1,159,319
Avg Vol (3m):871,832
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-1.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ZLCS

Comparison

Symbol% ChgMkt Cap
ZLCSUp 2.61%N/A
ACTUp 0.53%60.30B
NVSUp 4.13%226.97B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

As of July 15, 2014, Zalicus Inc. was acquired by EPIRUS Biopharmaceuticals, Inc., in a reverse merger transaction. Zalicus Inc., a biopharmaceutical company, discovers and develops novel treatments for patients suffering from pain. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback